[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100276448":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":57,"collaborators":60,"id":74,"slug":10,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":10,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":86,"studyType":87,"phases":10,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"University Hospital, Gasthuisberg","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Study group",null,{"label":12,"type":10,"description":10,"interventionNames":10},"control group",[14],{"name":15,"affiliation":16,"role":17},"Frédéric Amant, MD, PhD","UZ Gasthuisberg & KU Leuven, Belgium","PRINCIPAL_INVESTIGATOR",[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Katrien Van Tornout","CONTACT","+3216342876","katrien.vantornout@uzleuven.be",[25,41],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"UZ Gasthuisberg, Katholieke Universiteit Leuven","RECRUITING","Leuven","3000","Belgium","BE",{"type":33,"coordinates":34},"Point",[35,36],4.70093,50.87959,{"lat":36,"lon":35},[39,40],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"name":15,"role":17,"phone":10,"phoneExt":10,"email":10},{"facility":42,"status":27,"city":43,"state":10,"zip":10,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital","Amsterdam","Netherlands","NL",{"type":33,"coordinates":47},[48,49],4.88969,52.37403,{"lat":49,"lon":48},[52,55],{"name":53,"role":21,"phone":10,"phoneExt":10,"email":54},"Christianne Lok, MD, PhD","c.lok@nki.nl",{"name":53,"role":56,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"type":17,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Frederic Amant","MD PhD",[61,64,66,68,70,72],{"name":62,"class":63},"NKI-AvL","UNKNOWN",{"name":65,"class":6},"Medical University of Vienna",{"name":67,"class":6},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",{"name":69,"class":6},"Oslo University Hospital",{"name":71,"class":6},"Haukeland University Hospital",{"name":73,"class":63},"N.N. Blokchin NMRCO","100276448",false,"NCT02878434","Fertility Preservation in Young Women With Cancer","Fertility Preservation in Young Women With Cancer: an International Registration Study From the International Network on Cancer, Infertility and Pregnancy (INCIP)","Inclusion Criteria:\n\n* Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent","FEMALE","0 Years","40 Years",{"count":84,"type":85},2000,"ESTIMATED","5 Years","OBSERVATIONAL","The researchers aim to record the incidence, treatment and long term follow up of fertility preserving cancer treatment. Both the oncological and fertility outcome are recorded.\n\nStudy population: All patients with a cancer for whom a fertility preserving cancer treatment is applied. The results of the study population are compared to young women undergoing standard cancer treatment.",[90,91],"Cancer","Fertility",[90,91,93,94,95,96,97],"Pregnancy","Chemotherapy","Radiotherapy","Long term","Follow up","2020-11-17",{"date":100,"type":101},"2020-11-18","ACTUAL",{"date":103,"type":101},"2017-05-23",{"date":105,"type":85},"2032-07",{"name":5,"class":6},2]